Example: Heart Attack

Search clinical trials for: Oxacillin

Total 20 results

NCT01166932

Completed

Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumonia

Conditions: Community-Acquired Pneumonia
NCT00062647

Completed

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

Conditions: Gram-Positive Bacterial Infections
NCT02344511

Withdrawn

Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis

Conditions: Osteomyelitis
NCT00037050

Completed

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

Conditions: Bacterial Infections; Gram-Positive Bacterial Infections; Bacteremia
NCT00711802

Completed

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

Conditions: Skin Diseases, Infectious
NCT01104662

Terminated

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Conditions: Complicated Skin and Skin Structure Infections; S. Aureus Bacteremia; Renal Impairment
NCT01184872

Completed

Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections

Conditions: Infections
NCT00518076

Unknown status

Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant

Conditions: Staphylococcal Infections
NCT00428844

Completed

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Conditions: Osteomyelitis
NCT01626560

Completed

The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

Conditions: Cellulitis
NCT02701608

Recruiting

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

Conditions: Infective Endocarditis
NCT02208063

Terminated

A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

Conditions: Bacteremia
NCT01191840

Completed

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

Conditions: Bacteremia
NCT03723551

Active, not recruiting

Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus

Conditions: Bone or Joint Infection
NCT00077675

Completed

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Conditions: Infections, Gram-positive Bacterial
NCT00061633

Completed

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Conditions: Infections, Gram-Positive Bacterial; Abscess; Burns; Cellulitis; Ulcer; Wound Infections
NCT02099240

Unknown status

Patients Response to Early Switch To Oral:Osteomyelitis Study

Conditions: Osteomyelitis
NCT04037111

Recruiting

Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms

Conditions: Major Depressive Disorder; Rheumatoid Arthritis
NCT01756924

Terminated

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

Conditions: Prosthetic Joint Infections of Hip; Prosthetic Joint Infections of Knee; Infected Spacers
NCT02814916

Recruiting

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Conditions: Methicillin-Resistant Staphylococcus Aureus; Bacterial Infections; Staphylococcal Skin Infections